Novo Nordisk Inc Drug Patent Portfolio

Novo Nordisk Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Novo Nordisk Inc News

Novo Nordisk faces lawsuit for purportedly monopolizing the diabetes medication Victoza - Business Line

24 Jan, 2026

Sun Pharma receives approval to market generic Wegovy in India - WKZO

23 Jan, 2026

Initial approvals for generic semaglutide pave the way for market entry in India - Business Standard

23 Jan, 2026

Sun Pharma receives approval to introduce a generic version of semaglutide in India; market for anti-obesity medications...

23 Jan, 2026

See More